5Neri I,Demyttenaere K,Facchinetti F.Coping style and climacteric symptoms in a clinical sample of postmenopausal women[J].J Psychomsom Obstet Gynaecol,1997,18(3):229-233.
4Jacque E, Garnet L, Marcia L, et al.Risks and benefits of es- tro-gen plus ptcgestin in healthy pastmenopsusel women [J].JA- MA, 2002,288(3 ) : 1.
5Wakatsuki A, Okatani Y.Fukaya T, et al.Different effecb of o-ral conjugated equine estrogen end transdeimsl estrogen replace- ment therapy on size and oxidative susceptibility of low density lipoprotein particles in postmenopausal women [J].Circulafion, 2002,106(14) : 1771-1776.
6Rajewske J,Ryhakowski JK.Depression in premertopausal women gonadal hormones and serotonergic system assessed by D-fenfluramine cbellenge test[J].Prog Neuropsyehopharmaeol Biol Ptyehiatry, 2003,27(4) : 705-709.
7Parker WH,Broder MS,Liu Z,et al. Ovarian conservation at the time of hysterectomy for benign disease[ J]. Clin Obstet Gynecol, 2007,50(2) :354-361.
8Tanturovski D, Zafirova E, Stojovski M, et al. Impact of socio-de- mographic factm's on the delayed diagnosis and advanced stage presentation of patients with invasive cervical cancer in Macedo- nia[J]. Prilozi,2013,34(3) :71-78.
9Jahic M, Mulavdic M, Dautbasic F, et al. Frequency of Precancer- ous Changes and Cervical Cancer Recorded in Three Health Cen- tres in Tuzla Canton in Period 2010-2011 [ J]. Mater Sociomed, 2013,25(4) :259-261.
10Pirimoglu ZM, Ozyapi AG, Kars B, et al. Comparing the effects of intrauterine progestin system and oral progestin on health-related quality of life and Kupperman index in hormone replacement ther- apy[ J]. J Obstet Gynaecol Res,2011,37 (10) : 1376-1381.
